According to the SEC Form 4 filings, Shakil Ian, being in a position of
The largest sale of all time was on 2024-04-04 and amounted to 64055 shares of Augmedix, Inc. for $265,854.
No biography is available at this moment.
| 2024-05-15 | Sale | Augmedix, Inc. AUGX | CHIEF STRATEGY OFFICER | 1,387 0.0028% | $1.19 | $1,651 | +89.92% | |
| 2024-04-15 | Sale | Augmedix, Inc. AUGX | CHIEF STRATEGY OFFICER | 500 0.001% | $3.80 | $1,900 | -39.63% | |
| 2024-04-12 | Sale | Augmedix, Inc. AUGX | CHIEF STRATEGY OFFICER | 19,544 0.0402% | $3.82 | $74,590 | -40.42% | |
| 2024-04-11 | Sale | Augmedix, Inc. AUGX | CHIEF STRATEGY OFFICER | 24,778 0.0505% | $3.93 | $97,477 | -42.96% | |
| 2024-04-10 | Sale | Augmedix, Inc. AUGX | CHIEF STRATEGY OFFICER | 36,467 0.0753% | $3.87 | $141,288 | -41.04% | |
| 2024-04-09 | Sale | Augmedix, Inc. AUGX | CHIEF STRATEGY OFFICER | 31,542 0.066% | $4.14 | $130,521 | -44.36% | |
| 2024-04-08 | Sale | Augmedix, Inc. AUGX | CHIEF STRATEGY OFFICER | 37,780 0.0765% | $3.97 | $149,968 | -43.41% | |
| 2024-04-05 | Sale | Augmedix, Inc. AUGX | CHIEF STRATEGY OFFICER | 51,387 0.1055% | $4.03 | $207,233 | -43.42% | |
| 2024-04-04 | Sale | Augmedix, Inc. AUGX | CHIEF STRATEGY OFFICER | 64,055 0.1305% | $4.15 | $265,854 | -45.33% | |
| 2024-04-03 | Sale | Augmedix, Inc. AUGX | CHIEF STRATEGY OFFICER | 45,906 0.0926% | $4.11 | $188,600 | -45.22% | |
| 2024-04-02 | Sale | Augmedix, Inc. AUGX | CHIEF STRATEGY OFFICER | 38,463 0.0764% | $3.89 | $149,725 | -43.03% | |
| 2024-04-01 | Sale | Augmedix, Inc. AUGX | CHIEF STRATEGY OFFICER | 58,978 0.1176% | $3.91 | $230,384 | -43.03% | |
| 2024-03-28 | Sale | Augmedix, Inc. AUGX | CHIEF STRATEGY OFFICER | 31,994 0.0667% | $4.06 | $129,851 | -44.01% |